Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Merck & Co., Inc. MRK
$116.82
-$0.73 (-0.62%)
На 18:00, 12 мая 2023
-12.80%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
296321989456.00000000
-
week52high
119.65
-
week52low
83.05
-
Revenue
59283000000
-
P/E TTM
69
-
Beta
0.35259500
-
EPS
5.13000000
-
Last Dividend
2.92000000
-
Next Earnings Date
01 авг 2023 г. в 12:00
Описание компании
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| SVB Leerink | Outperform | Outperform | 29 июл 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 29 июл 2022 г. |
| Barclays | Overweight | Overweight | 29 июл 2022 г. |
| UBS | Neutral | Neutral | 18 июл 2022 г. |
| Atlantic Equities | Overweight | Overweight | 13 июл 2022 г. |
| Erste Group | Buy | Hold | 25 авг 2022 г. |
| Berenberg | Buy | Hold | 14 сент 2022 г. |
| SVB Leerink | Outperform | Outperform | 12 сент 2022 г. |
| SVB Leerink | Outperform | Outperform | 30 сент 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 12 окт 2022 г. |
| Atlantic Equities | Overweight | Overweight | 11 окт 2022 г. |
| Guggenheim | Buy | Neutral | 10 окт 2022 г. |
| Wells Fargo | Overweight | Overweight | 28 окт 2022 г. |
| Truist Securities | Buy | Buy | 28 окт 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 28 окт 2022 г. |
| Barclays | Overweight | Overweight | 28 окт 2022 г. |
| Guggenheim | Buy | Buy | 01 ноя 2022 г. |
| Credit Suisse | Outperform | 18 ноя 2022 г. | |
| B of A Securities | Buy | Neutral | 04 янв 2023 г. |
| Wells Fargo | Overweight | Overweight | 03 янв 2023 г. |
| Cantor Fitzgerald | Overweight | Overweight | 19 дек 2022 г. |
| SVB Leerink | Outperform | Outperform | 23 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Oosthuizen Johannes Jacobus | A | 18822 | 2091 | 23 янв 2023 г. |
| Williams David Michael | A | 11008 | 1745 | 23 янв 2023 г. |
| Karachun Rita A | A | 43949 | 2846 | 23 янв 2023 г. |
| MIZELL STEVEN | A | 44336 | 12192 | 23 янв 2023 г. |
| Zachary Jennifer | A | 53920 | 15631 | 23 янв 2023 г. |
| Davis Robert M | A | 271817 | 24224 | 23 янв 2023 г. |
| Li Dean Y | A | 19933 | 3275 | 23 янв 2023 г. |
| DeLuca Richard R. | A | 153500 | 15628 | 23 янв 2023 г. |
| Litchfield Caroline | A | 30187 | 2656 | 23 янв 2023 г. |
| Klobuchar Michael A | A | 17990 | 2651 | 23 янв 2023 г. |
Institutional Ownership
Institutional Ownership
| Holder | Shares | Change | Date Reported |
|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 71121900 | -628140 | 31 авг 2020 г. |
| Vanguard 500 Index Fund | 51863100 | -187159 | 31 авг 2020 г. |
| SPDR S&P 500 ETF | 26613700 | -126243 | 31 авг 2020 г. |
| US Bank Vanguard Institutional 500 Index Trust | 21686200 | -99900 | 31 авг 2020 г. |
| iShares Core S&P 500 ETF | 19097600 | -103768 | 31 авг 2020 г. |
| Vanguard Value Index Fund | 16913600 | 219963 | 31 авг 2020 г. |
| Health Care Select Sector SPDR Fund | 15396300 | 97870 | 31 авг 2020 г. |
| Fidelity 500 Index Fund | 22483300 | -24332 | 31 июл 2020 г. |
| American Funds Income Fund of America | 15744900 | -3759570 | 30 июн 2020 г. |
| American Funds Washington Mutual Investors Fund | 15705900 | 972768 | 30 июн 2020 г. |
Новостная лента
OPKO Health's Future After Merck Deal: Bright Or Uncertain
Seeking Alpha
11 мая 2023 г. в 12:29
In the first three months of 2023, the company posted $237.6 million in revenue, up 28.2% from the previous quarter. In addition to the Merck deal, OPKO received a $7 million payment from Vifor in Q1 2023, thanks to the German price approval for Rayaldee.
Should You Buy Merck Stock At $120?
Forbes
09 мая 2023 г. в 07:00
Although the company posted upbeat Q1 results late last month, we believe MRK stock is fully valued.
2 Top Healthcare Stocks Defying the Bear Market
The Motley Fool
07 мая 2023 г. в 08:14
Eli Lilly's tirzepatide could be a weight-loss blockbuster. Merck continues to add indications for oncology therapy Keytruda.
5 Conservative And Cheap Dividend Stocks To Invest In - May 2023
Seeking Alpha
06 мая 2023 г. в 09:00
This article is part of our monthly series where we highlight five companies that are large-cap, relatively safe, dividend-paying and are offering large discounts to their historical norms. We go over our filtering process to select just five conservative DGI stocks from more than 7,500 companies that are traded on U.S. exchanges, including OTC networks.
Here is What to Know Beyond Why Merck & Co., Inc. (MRK) is a Trending Stock
Zacks Investment Research
04 мая 2023 г. в 10:41
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.